Analysis demonstrated that HH signaling genes (e.g., PTCH1, GLI1, GLI2, GLI3, and GLI4) are biomarkers due to their greater connectivity with the HCC gene network. This evidence concerns the gene PTCH1 and hepatocellular carcinoma.